Fundamental Data for PFE

Pfizer Inc is a research-based, global pharmaceutical company that discovers and develops innovative, value-added products that improve the quality of life of people around the world and help them enjoy longer, healthier, and more productive lives. Pfizer has three business segments: health care, animal health and consumer health care. Its products are available in numerous countries. (Company Press Release)

# Employees: 81800

Address: 235 East 42nd Street,New York,NY,USA

Phone: 212 573-2323

Fax: 212 573-7851

Website: www.pfizer.com

Email:

Sector: Medical

Industry: MED-DRUGS

Executive Officers

Jeffrey B. Kindler (Chmn.; C.E.O.)

Frank A. D???amelio (Sr. V.P.; C.F.O.)

Sally Susman (Sr. V.P.; Chief Communications Off.)

James M. Kilts (Dir.)

David L. Shedlarz (Vice Chmn.,)

Dividend

Ex-Dividend Date: 11/4/2009

Annual Dividend: $0.64

Current Dividend Yield: $3.51

Dividend Paid (3 months): $0.16

Indicated Dividend: $0.29

Earnings

Last Earnings Date: 9/30/2009

Next Earnings Date(Expected): 1/25/2010

Mean EPS (Next Qtr): $0.48

Mean EPS (Year): $2.02

Mean Estimate(Long Term): ($0.67)

P/E Ratio(Based on EPS estimate): 9.020

Number of Estimates: 18

Shares Performance

Period	PFE	Compare to S&P
YTD	3.05 %	-14.72 %
4 Weeks	7.16 %	1.73 %
12 Weeks	11.35 %	3.69 %

Shares Information

Analyst Coverage: Y

Avg Volume: 44562888

Shares Outstanding: 6749M

Market Cap: $123.17B

52 Week High: $18.59

52 Week Low: $11.66

P/E Ratio: 8.370

PEG Ratio: -13.530

Split: On 7/1/1999 PFE split by factor of 3.000

Earnings Performance

EPS Growth in Last Quarter: 6.25 %

EPS Growth in Last Year: -17.74 %

Sales Growth in Last Quarter: 5.80 %

Sales Growth in Last Quarter: -2.94 %

Financials

Qtr Book Value: $1.86

Cash Flow/Share: $5.74

Change in Payout Ratio: -0.160

Price/Sales: 2.690